Cargando…
Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy
Diabetic nephropathy (DN) is one the most prevalent chronic complications of diabetes mellitus that affects as much as one-third of diabetic patients irrespective of the type of diabetes. Hyperglycemia is the key trigger for DN that initiates a number of microscopic and ultramicroscopic changes in k...
Autores principales: | Bhatti, Adnan Bashir, Usman, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699926/ https://www.ncbi.nlm.nih.gov/pubmed/26798569 http://dx.doi.org/10.7759/cureus.393 |
Ejemplares similares
-
Can Aliskiren be Considered as a New Novel Drug for Hypertension?
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015) -
Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy
por: Mukhi, Dhanunjay, et al.
Publicado: (2017) -
Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015) -
MicroRNAs in Podocyte Injury in Diabetic Nephropathy
por: Ishii, Hiroki, et al.
Publicado: (2020) -
MicroRNAs for podocyte injury in diabetic nephropathy
por: Morishita, Yoshiyuki
Publicado: (2021)